Home » Topics » Regulatory » Patents

Patents
RSS

Bayer designs novel TTK protein kinase inhibitors

Dec. 21, 2012

New tyrosine kinase inhibitors patented

Dec. 21, 2012

New serotonin 5-HT7 receptor ligands designed by Italian scientists

Dec. 21, 2012

University of Toyama prepares new beta-carboline derivatives for cancer

Dec. 20, 2012

Novel antitumor metal complexes designed by Unitech

Dec. 20, 2012

NewGen Therapeutics patents new agents for cancer

Dec. 20, 2012

Concert Pharmaceuticals synthesizes new deuterated CFTR activators

Dec. 20, 2012

Principia Biopharma discloses new protein kinase inhibitors

Dec. 20, 2012

Japanese and U.S. group patents novel TRPV1 channel antagonists

Dec. 20, 2012

Researchers at institutes in California present new protein kinase inhibitors

Dec. 19, 2012

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...